chRCC is a rare subtype of RCC; however, its genetic alterations in the PI3K/AKT signaling pathway are highly significant, with approximately 32% of patients exhibiting mutations or deletions of pathway‐related components.31 The gene discussed is AKT1; the disease is renal cell carcinoma.